ByteBrief

Best read upright.

We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.

(We tried widescreen once. It wasn't us.)

ByteBrief

HealthForbes Innovationabout 3 hours ago

Why An AI Biotech Startup Launched A $600 Million Fund To Buy Stalled Drugs

ByteBrief summary

1 min read

Most AI drug development firms are focused on discovery. AI biotech Formation Bio is betting the real bottleneck is clinical trials. With a new $600 million fund to buy or license potential drugs that have stalled out, the startup now hopes to prove that it's right.

Level

Hype check

Tap to vote and see what everyone thinks.

#biotech #ai #funding

Best read upright.

Why An AI Biotech Startup Launched A $600 Million Fund To Buy Stalled Drugs

More to chew on!

More to chew on!